iRhythm's LTCM showed superior performance in arrhythmia diagnosis, fewer retests, and lower cardiovascular events compared to other ACMs. The study used inverse probability of treatment weighting to ...

Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy With improved cancer treatments and a rising survivorship population, it is ...

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for its Assert-IQTM insertable cardiac monitor (ICM), giving doctors a new choice for the diagnostic assessment and ...

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer Osimertinib is a third-generation, CNS-active, irreversible, oral epidermal growth ...

"One concept to take away is that cardiologists, oncologists, and primary care physicians need to work together to promote cardiovascular health in patients with cancer and in cancer survivors." ...

Sometimes, a study on one topic can reveal important issues in another. Case in point: A recent Lancet study explored what a person’s life was like before they developed chronic pain — the diseases ...

A breakthrough in MRI technology offers a safer alternative to risky heart procedures. Researchers at the University of East ...

Partnership leverages ARTELLA’S Active State Monitoring SaaS platform and Certified Independent Diagnostic Testing Facility (IDTF) with Future Cardia’s Implantable Cardiac Devices. The companies began ...

'There was not a barrier that she couldn't move out of the way,' Yale New Haven Hospital CNO says of innovator Michele Santoro, RN. With Michele Santoro’s self-described “questioning attitude,” she ...